Checkmate Pharmaceuticals, Inc.
CMPIDelisted May 31, 2022- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001651431
Checkmate Pharmaceuticals, Inc. was delisted on May 31, 2022; its insiders filed their last Form 4 on May 31, 2022; 26 institutions reported holding it in 13F filings for Q1 2022, worth $54.8M in total; no superinvestor held it.
13F holders, Q3 2021
Institutional positions in Checkmate Pharmaceuticals, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 32
- −2 vs. Q2 2021
- Shares held
- 16.4M
- +30.5K (+0.2%) vs. Q2 2021
- Total value
- $64.5M
- −$32.8M (−33.7%) vs. Q2 2021
- New holders
- 4
- 5 more added
- Sold out
- 6
- 8 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CMPI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 26 | $54.8M |
| Q4 2021 | 25 | $46.3M |
| Q3 2021 | 32 | $64.5M |
| Q2 2021 | 34 | $97.3M |
| Q1 2021 | 37 | $202.5M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Checkmate Pharmaceuticals, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 33 | $0 | 0.00% | +1+3.1% | Added |
| Hall Laurie J Trustee | 100,530 | $0 | 0.00% | +100,530 | New |
| JPMorgan Chase & Co | 185 | $1.00K | 0.00% | −4,972−96.4% | Reduced |
| UBS Group AG | 183 | $1.00K | 0.00% | −3,113−94.4% | Reduced |
| Royal Bank of Canada | 168 | $1.00K | 0.00% | −2,219−93.0% | Reduced |
| Johnson Midwest Financial, LLC | 200 | $1.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,426 | $6.00K | 0.00% | +1,426 | New |
| US Bancorp | 2,000 | $8.00K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 3,370 | $14.0K | 0.00% | −2,961−46.8% | Reduced |
| Morgan Stanley | 4,120 | $16.0K | 0.00% | +3,728+951.0% | Added |
| The PNC Financial Services Group, Inc. | 5,000 | $20.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 10,667 | $42.0K | 0.00% | −12,833−54.6% | Reduced |
| State Street Corp | 11,087 | $44.0K | 0.00% | +11,087 | New |
| HRT Financial LP | 18,298 | $72.0K | 0.00% | −5,823−24.1% | Reduced |
| Federated Hermes, Inc. | 20,000 | $79.0K | 0.00% | +3,831+23.7% | Added |
| Cambridge Trust Co | 24,609 | $98.0K | 0.00% | 00.0% | Unchanged |
| Ergoteles LLC | 25,870 | $103.0K | 0.00% | −557−2.1% | Reduced |
| Jacobs Levy Equity Management, Inc | 36,511 | $145.0K | 0.00% | +36,511 | New |
| Geode Capital Management, LLC | 40,260 | $159.0K | 0.00% | −120.0% | Reduced |
| BlackRock Inc. | 51,794 | $205.0K | 0.00% | +28,944+126.7% | Added |
| RBF Capital, LLC | 68,834 | $273.0K | 0.02% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 106,500 | $423.0K | 0.01% | +85,000+395.3% | Added |
| Ensign Peak Advisors, Inc | 119,915 | $476.0K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 336,587 | $1.34M | 0.00% | 00.0% | Unchanged |
| Sectoral Asset Management Inc | 541,766 | $2.15M | 0.18% | 00.0% | Unchanged |
| FMR LLC | 966,226 | $3.84M | 0.00% | 00.0% | Unchanged |
| Omega Fund Management, LLC | 1,335,050 | $5.30M | 0.59% | 00.0% | Unchanged |
| Medicxi Ventures Management (Jersey) Ltd | 1,501,716 | $5.96M | 1.30% | 00.0% | Unchanged |
| Clough Capital Partners L P | 1,567,326 | $6.22M | 0.39% | 00.0% | Unchanged |
| Novo Holdings A/S | 2,170,100 | $8.62M | 0.45% | 00.0% | Unchanged |
| Sofinnova Investments, Inc. | 3,606,707 | $14.3M | 0.92% | 00.0% | Unchanged |
| venBio Partners LLC | 3,673,374 | $14.6M | 1.45% | 00.0% | Unchanged |
| Deutsche Bank AG | 0 | $0 | 0.00% | −134,760−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −40,422−100.0% | Sold out |
| Alberta Investment Management Corp | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −7,800−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −77−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −1−100.0% | Sold out |